[1]
Kovacs G, Olschewski H. The definition of pulmonary hypertension: history, practical implications and current controversies. Breathe (Sheffield, England). 2021 Sep:17(3):210076. doi: 10.1183/20734735.0076-2021. Epub
[PubMed PMID: 35035548]
[2]
Yaghi S, Novikov A, Trandafirescu T. Clinical update on pulmonary hypertension. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2020 Apr:68(4):821-827. doi: 10.1136/jim-2020-001291. Epub 2020 Apr 1
[PubMed PMID: 32241822]
[3]
Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. The European respiratory journal. 2019 Jan:53(1):. doi: 10.1183/13993003.01913-2018. Epub 2019 Jan 24
[PubMed PMID: 30545968]
[4]
Mandras SA, Mehta HS, Vaidya A. Pulmonary Hypertension: A Brief Guide for Clinicians. Mayo Clinic proceedings. 2020 Sep:95(9):1978-1988. doi: 10.1016/j.mayocp.2020.04.039. Epub
[PubMed PMID: 32861339]
[5]
Montani D, O'Callaghan DS, Savale L, Jaïs X, Yaïci A, Maitre S, Dorfmuller P, Sitbon O, Simonneau G, Humbert M. Pulmonary veno-occlusive disease: recent progress and current challenges. Respiratory medicine. 2010 Jul:104 Suppl 1():S23-32. doi: 10.1016/j.rmed.2010.03.014. Epub 2010 Apr 24
[PubMed PMID: 20456932]
[6]
Montani D, Achouh L, Dorfmüller P, Le Pavec J, Sztrymf B, Tchérakian C, Rabiller A, Haque R, Sitbon O, Jaïs X, Dartevelle P, Maître S, Capron F, Musset D, Simonneau G, Humbert M. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine. 2008 Jul:87(4):220-233. doi: 10.1097/MD.0b013e31818193bb. Epub
[PubMed PMID: 18626305]
Level 3 (low-level) evidence
[7]
Boucly A, Girerd B, Bourlier D, Nemlaghi S, Caliez J, Savale L, Jaïs X, Dorfmüller P, Simonneau G, Sitbon O, Humbert M, Montani D. [Pulmonary veno-occlusive disease]. Revue des maladies respiratoires. 2018 Feb:35(2):160-170. doi: 10.1016/j.rmr.2017.11.005. Epub 2018 Mar 1
[PubMed PMID: 29501213]
[8]
Holcomb BW Jr, Loyd JE, Ely EW, Johnson J, Robbins IM. Pulmonary veno-occlusive disease: a case series and new observations. Chest. 2000 Dec:118(6):1671-9
[PubMed PMID: 11115457]
Level 2 (mid-level) evidence
[9]
Hajouli S, Moustafa MA, Memoli JSW. Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension. Journal of investigative medicine high impact case reports. 2019 Jan-Dec:7():2324709619840375. doi: 10.1177/2324709619840375. Epub
[PubMed PMID: 31010327]
Level 3 (low-level) evidence
[10]
Voordes CG, Kuipers JR, Elema JD. Familial pulmonary veno-occlusive disease: a case report. Thorax. 1977 Dec:32(6):763-6
[PubMed PMID: 601742]
Level 3 (low-level) evidence
[11]
Eyries M, Montani D, Girerd B, Perret C, Leroy A, Lonjou C, Chelghoum N, Coulet F, Bonnet D, Dorfmüller P, Fadel E, Sitbon O, Simonneau G, Tregouët DA, Humbert M, Soubrier F. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension. Nature genetics. 2014 Jan:46(1):65-9. doi: 10.1038/ng.2844. Epub 2013 Dec 1
[PubMed PMID: 24292273]
[12]
Manaud G, Nossent EJ, Lambert M, Ghigna MR, Boët A, Vinhas MC, Ranchoux B, Dumas SJ, Courboulin A, Girerd B, Soubrier F, Bignard J, Claude O, Lecerf F, Hautefort A, Florio M, Sun B, Nadaud S, Verleden SE, Remy S, Anegon I, Bogaard HJ, Mercier O, Fadel E, Simonneau G, Vonk Noordegraaf A, Grünberg K, Humbert M, Montani D, Dorfmüller P, Antigny F, Perros F. Comparison of Human and Experimental Pulmonary Veno-Occlusive Disease. American journal of respiratory cell and molecular biology. 2020 Jul:63(1):118-131. doi: 10.1165/rcmb.2019-0015OC. Epub
[PubMed PMID: 32209028]
[13]
Zeng X, Chen F, Rathinasabapathy A, Li T, Adnan Ali Mohammed Mohammed A, Yu Z. Rapid disease progress in a PVOD patient carrying a novel EIF(2)AK(4) mutation: a case report. BMC pulmonary medicine. 2020 Jul 6:20(1):186. doi: 10.1186/s12890-020-01186-8. Epub 2020 Jul 6
[PubMed PMID: 32631303]
Level 3 (low-level) evidence
[14]
Zeng Q, Yang H, Liu B, Ma Y, Liu Z, Chen Q, Li W, Luo Q, Zhao Z, Zhou Z, Xiong C. Clinical characteristics and survival of Chinese patients diagnosed with pulmonary arterial hypertension who carry BMPR2 or EIF2KAK4 variants. BMC pulmonary medicine. 2020 May 29:20(1):150. doi: 10.1186/s12890-020-01179-7. Epub 2020 May 29
[PubMed PMID: 32471403]
[15]
Liang L, Ma G, Chen K, Liu Y, Wu X, Ying K, Zhang R. EIF2AK4 mutation in pulmonary veno-occlusive disease: A case report and review of the literature. Medicine. 2016 Sep:95(39):e5030. doi: 10.1097/MD.0000000000005030. Epub
[PubMed PMID: 27684876]
Level 3 (low-level) evidence
[16]
Austin ED, Loyd JE, Phillips JA 3rd. Genetics of pulmonary arterial hypertension. Seminars in respiratory and critical care medicine. 2009 Aug:30(4):386-98. doi: 10.1055/s-0029-1233308. Epub 2009 Jul 24
[PubMed PMID: 19634078]
[17]
Runo JR, Vnencak-Jones CL, Prince M, Loyd JE, Wheeler L, Robbins IM, Lane KB, Newman JH, Johnson J, Nichols WC, Phillips JA 3rd. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. American journal of respiratory and critical care medicine. 2003 Mar 15:167(6):889-94
[PubMed PMID: 12446270]
[18]
Aldred MA, Vijayakrishnan J, James V, Soubrier F, Gomez-Sanchez MA, Martensson G, Galie N, Manes A, Corris P, Simonneau G, Humbert M, Morrell NW, Trembath RC. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. Human mutation. 2006 Feb:27(2):212-3
[PubMed PMID: 16429403]
[19]
Perros F, Günther S, Ranchoux B, Godinas L, Antigny F, Chaumais MC, Dorfmüller P, Hautefort A, Raymond N, Savale L, Jaïs X, Girerd B, Cottin V, Sitbon O, Simonneau G, Humbert M, Montani D. Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models. Circulation. 2015 Sep 1:132(9):834-47. doi: 10.1161/CIRCULATIONAHA.115.014207. Epub 2015 Jun 30
[PubMed PMID: 26130118]
Level 3 (low-level) evidence
[20]
Kunadu A, Stalls JS, Labuschagne H, Thayyil A, Falls R, Maddipati V. Mitomycin induced pulmonary veno-occlusive disease. Respiratory medicine case reports. 2021:34():101437. doi: 10.1016/j.rmcr.2021.101437. Epub 2021 Jun 1
[PubMed PMID: 34401312]
Level 3 (low-level) evidence
[21]
Zhang C, Lu W, Luo X, Liu S, Li Y, Zheng Q, Liu W, Wu X, Chen Y, Jiang Q, Zhang Z, Gu G, Chen J, Chen H, Liao J, Liu C, Hong C, Tang H, Sun D, Yang K, Wang J. Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in rats. British journal of pharmacology. 2021 Jan:178(1):217-235. doi: 10.1111/bph.15314. Epub 2020 Dec 14
[PubMed PMID: 33140842]
[22]
Certain MC, Chaumais MC, Jaïs X, Savale L, Seferian A, Parent F, Georges M, Favrolt N, Bourdin A, Boissin C, Cottin V, Traclet J, Renard S, Noel V, Picard F, Girerd B, Ghigna MR, Perros F, Sitbon O, Bonniaud P, Humbert M, Montani D. Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C. Chest. 2021 Mar:159(3):1197-1207. doi: 10.1016/j.chest.2020.09.238. Epub 2020 Sep 24
[PubMed PMID: 32979348]
[23]
Montani D, Lau EM, Descatha A, Jaïs X, Savale L, Andujar P, Bensefa-Colas L, Girerd B, Zendah I, Le Pavec J, Seferian A, Perros F, Dorfmüller P, Fadel E, Soubrier F, Sitbon O, Simonneau G, Humbert M. Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease. The European respiratory journal. 2015 Dec:46(6):1721-31. doi: 10.1183/13993003.00814-2015. Epub 2015 Nov 5
[PubMed PMID: 26541523]
[24]
Dorfmüller P, Humbert M, Perros F, Sanchez O, Simonneau G, Müller KM, Capron F. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Human pathology. 2007 Jun:38(6):893-902
[PubMed PMID: 17376507]
[25]
Gupta S, Gupta A, Rehman S, Ocak I, Domsic RT, Schneider F, George MP. Pulmonary veno-occlusive disease is highly prevalent in scleroderma patients undergoing lung transplantation. ERJ open research. 2019 Feb:5(1):. pii: 00168-2018. doi: 10.1183/23120541.00168-2018. Epub 2019 Feb 11
[PubMed PMID: 30775371]
[26]
Johnson SR, Patsios D, Hwang DM, Granton JT. Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension. The Journal of rheumatology. 2006 Nov:33(11):2347-50
[PubMed PMID: 16981286]
[27]
Duarte AC, Cordeiro A, Loureiro MJ, Ferreira F. Pulmonary veno-occlusive disease: a probably underdiagnosed cause of pulmonary hypertension in systemic sclerosis. Clinical rheumatology. 2020 May:39(5):1687-1691. doi: 10.1007/s10067-020-04953-4. Epub 2020 Jan 22
[PubMed PMID: 31965379]
[28]
Kramer MR, Estenne M, Berkman N, Antoine M, de Francquen P, Lipski A, Jacobovitz D, Lafair J. Radiation-induced pulmonary veno-occlusive disease. Chest. 1993 Oct:104(4):1282-4
[PubMed PMID: 8404211]
[29]
Kreft A, Alverson C, Wagner-Drouet EM, Ries I, Sommer C, Dr Re Nat MS. Veno-occlusive disease of the lung after allogeneic haematopoietic stem-cell transplantation: An autopsy study. Pathology, research and practice. 2022 Mar:231():153799. doi: 10.1016/j.prp.2022.153799. Epub 2022 Feb 11
[PubMed PMID: 35180649]
[30]
Escamilla R, Hermant C, Berjaud J, Mazerolles C, Daussy X. Pulmonary veno-occlusive disease in a HIV-infected intravenous drug abuser. The European respiratory journal. 1995 Nov:8(11):1982-4
[PubMed PMID: 8620974]
[31]
Hourseau M, Capron F, Nunes H, Godmer P, Martin A, Kambouchner M. [Pulmonary veno-occlusive disease in a patient with HIV infection. A case report with autopsy findings]. Annales de pathologie. 2002 Dec:22(6):472-5
[PubMed PMID: 12594391]
Level 3 (low-level) evidence
[32]
Montani D, Lau EM, Dorfmüller P, Girerd B, Jaïs X, Savale L, Perros F, Nossent E, Garcia G, Parent F, Fadel E, Soubrier F, Sitbon O, Simonneau G, Humbert M. Pulmonary veno-occlusive disease. The European respiratory journal. 2016 May:47(5):1518-34. doi: 10.1183/13993003.00026-2016. Epub 2016 Mar 23
[PubMed PMID: 27009171]
[33]
Szturmowicz M, Kacprzak A, Szołkowska M, Burakowska B, Szczepulska E, Kuś J. Pulmonary veno-occlusive disease: pathogenesis, risk factors, clinical features and diagnostic algorithm - state of the art. Advances in respiratory medicine. 2018:86(3):. doi: 10.5603/ARM.2018.0021. Epub
[PubMed PMID: 29960280]
Level 3 (low-level) evidence
[34]
Montani D, Kemp K, Dorfmuller P, Sitbon O, Simonneau G, Humbert M. Idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: similarities and differences. Seminars in respiratory and critical care medicine. 2009 Aug:30(4):411-20. doi: 10.1055/s-0029-1233310. Epub 2009 Jul 24
[PubMed PMID: 19634080]
[35]
Montani D, Price LC, Dorfmuller P, Achouh L, Jaïs X, Yaïci A, Sitbon O, Musset D, Simonneau G, Humbert M. Pulmonary veno-occlusive disease. The European respiratory journal. 2009 Jan:33(1):189-200. doi: 10.1183/09031936.00090608. Epub
[PubMed PMID: 19118230]
[36]
Levine DJ. Pulmonary arterial hypertension: updates in epidemiology and evaluation of patients. The American journal of managed care. 2021 Mar:27(3 Suppl):S35-S41. doi: 10.37765/ajmc.2021.88609. Epub
[PubMed PMID: 33710842]
[37]
Bunte MC, Patnaik MM, Pritzker MR, Burns LJ. Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction. Bone marrow transplantation. 2008 Apr:41(8):677-86. doi: 10.1038/sj.bmt.1705990. Epub 2008 Jan 28
[PubMed PMID: 18223697]
[38]
Tatius B, Wasityastuti W, Astarini FD, Nugrahaningsih DAA. Significance of BMPR2 mutations in pulmonary arterial hypertension. Respiratory investigation. 2021 Jul:59(4):397-407. doi: 10.1016/j.resinv.2021.03.011. Epub 2021 May 20
[PubMed PMID: 34023242]
[39]
Montani D, Girerd B, Jaïs X, Levy M, Amar D, Savale L, Dorfmüller P, Seferian A, Lau EM, Eyries M, Le Pavec J, Parent F, Bonnet D, Soubrier F, Fadel E, Sitbon O, Simonneau G, Humbert M. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study. The Lancet. Respiratory medicine. 2017 Feb:5(2):125-134. doi: 10.1016/S2213-2600(16)30438-6. Epub 2017 Jan 11
[PubMed PMID: 28087362]
[40]
Donnelly N, Gorman AM, Gupta S, Samali A. The eIF2α kinases: their structures and functions. Cellular and molecular life sciences : CMLS. 2013 Oct:70(19):3493-511. doi: 10.1007/s00018-012-1252-6. Epub 2013 Jan 26
[PubMed PMID: 23354059]
[41]
Pietra GG, Edwards WD, Kay JM, Rich S, Kernis J, Schloo B, Ayres SM, Bergofsky EH, Brundage BH, Detre KM. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation. 1989 Nov:80(5):1198-206
[PubMed PMID: 2805258]
Level 2 (mid-level) evidence
[43]
Resten A, Maitre S, Humbert M, Rabiller A, Sitbon O, Capron F, Simonneau G, Musset D. Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease. AJR. American journal of roentgenology. 2004 Jul:183(1):65-70
[PubMed PMID: 15208112]
[44]
Elliott CG, Colby TV, Hill T, Crapo RO. Pulmonary veno-occlusive disease associated with severe reduction of single-breath carbon monoxide diffusing capacity. Respiration; international review of thoracic diseases. 1988:53(4):262-6
[PubMed PMID: 3175350]
[45]
Bailey CL, Channick RN, Auger WR, Fedullo PF, Kerr KM, Yung GL, Rubin LJ. "High probability" perfusion lung scans in pulmonary venoocclusive disease. American journal of respiratory and critical care medicine. 2000 Nov:162(5):1974-8
[PubMed PMID: 11069842]
[46]
Seferian A, Helal B, Jaïs X, Girerd B, Price LC, Günther S, Savale L, Dorfmüller P, Parent F, Sitbon O, Humbert M, Simonneau G, Montani D. Ventilation/perfusion lung scan in pulmonary veno-occlusive disease. The European respiratory journal. 2012 Jul:40(1):75-83. doi: 10.1183/09031936.00097911. Epub 2011 Nov 16
[PubMed PMID: 22088969]
[47]
Chawla SK, Kittle CF, Faber LP, Jensik RJ. Pulmonary venoocclusive disease. The Annals of thoracic surgery. 1976 Sep:22(3):249-53
[PubMed PMID: 962409]
[48]
Ogawa A, Sakao S, Tanabe N, Matsubara H, Tatsumi K. Use of vasodilators for the treatment of pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: A systematic review. Respiratory investigation. 2019 Mar:57(2):183-190. doi: 10.1016/j.resinv.2018.10.004. Epub 2018 Nov 23
[PubMed PMID: 30473253]
Level 1 (high-level) evidence
[49]
Montani D, Jaïs X, Price LC, Achouh L, Degano B, Mercier O, Mussot S, Fadel E, Dartevelle P, Sitbon O, Simonneau G, Humbert M. Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease. The European respiratory journal. 2009 Dec:34(6):1348-56. doi: 10.1183/09031936.00017809. Epub 2009 Jun 18
[PubMed PMID: 19541723]
[50]
Naniwa T, Takeda Y. Long-term remission of pulmonary veno-occlusive disease associated with primary Sjögren's syndrome following immunosuppressive therapy. Modern rheumatology. 2011 Dec:21(6):637-40. doi: 10.1007/s10165-011-0440-9. Epub 2011 Mar 11
[PubMed PMID: 21394665]
[51]
Bergbaum C, Samaranayake CB, Pitcher A, Weingart E, Semple T, Kokosi M, Wells AU, Montani D, Dimopoulos K, McCabe C, Kempny A, Harries C, Orchard E, Wort SJ, Price LC. A case series on the use of steroids and mycophenolate mofetil in idiopathic and heritable pulmonary veno-occlusive disease: is there a role for immunosuppression? The European respiratory journal. 2021 Jun:57(6):. pii: 2004354. doi: 10.1183/13993003.04354-2020. Epub 2021 Jun 24
[PubMed PMID: 33863739]
Level 2 (mid-level) evidence
[52]
Wille KM, Sharma NS, Kulkarni T, Lammi MR, Barney JB, Bellot SC, Cantor RS, Naftel DC, Diaz-Guzman E, McGiffin DC. Characteristics of patients with pulmonary venoocclusive disease awaiting transplantation. Annals of the American Thoracic Society. 2014 Nov:11(9):1411-8. doi: 10.1513/AnnalsATS.201408-354OC. Epub
[PubMed PMID: 25296345]
[53]
Karakurt Z. [Other causes of pulmonary arterial hypertension: pulmonary veno-occlusive disease, pulmonary capillary hemangiomatosis, porto-pulmonary hypertension, HIV- associated pulmonary arterial hypertension]. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology. 2010 Aug:10 Suppl 1():63-8. doi: 10.5152/akd.2010.121. Epub
[PubMed PMID: 20819769]
[54]
Naeije R, Manes A. The right ventricle in pulmonary arterial hypertension. European respiratory review : an official journal of the European Respiratory Society. 2014 Dec:23(134):476-87. doi: 10.1183/09059180.00007414. Epub
[PubMed PMID: 25445946]